| Yvonne Marie Brutger, MD | |
|
3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 | |
| (763) 520-5609 | |
| Not Available |
| Full Name | Yvonne Marie Brutger |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 3300 Oakdale Ave N, Robbinsdale, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063510808 | NPI | - | NPPES |
| 83268500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 27534 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Yvonne Marie Brutger, MD 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5609 | Yvonne Marie Brutger, MD 3300 Oakdale Ave N, Robbinsdale, MN 55422-2926 Ph: (763) 520-5609 |
News Archive
Pharmasset, Inc., a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2011.
A new survey conducted by the National Pest Management Association and the University of Kentucky, confirms what pest management professionals across the U.S. and around the world have been seeing in the field - bed bugs are back in a very big way, with 95 percent of U.S. survey respondents indicating that their company has encountered a bed bug infestation in the past year. Prior to 2000, only 25 percent of U.S. survey respondents encountered a bed bug infestation.
Several drugs currently in use or in development control parasitic worms in the same way. That concerns health workers In developing countries where reinfestations often require repeated treatments. If worms develop resistance to one drug, the other treatments would likely fail as well.
Seven million Medicare beneficiaries who are eligible for low-income transitional assistance and additional discounts can see very large savings on their prescription drugs through their Medicare-Approved Drug Discount Cards.
Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.
› Verified 6 days ago
Dr. Paul Andrew Travnicek, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3300 Oakdale Ave N, Emergency Center, 11102f, Robbinsdale, MN 55422 Phone: 763-520-2000 | |
Dr. David Clayton Johnston, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5609 Fax: 763-520-7564 | |
James C Tyson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5609 Fax: 763-520-7562 | |
Rebecca K. S. Ansari, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5609 | |
Thomas Timmons, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5609 Fax: 763-520-7562 | |
Paul A Satterlee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Robbinsdale, MN 55422 Phone: 763-520-5609 Fax: 763-520-7562 |